nodes	percent_of_prediction	percent_of_DWPC	metapath
Adefovir Dipivoxil—NME1—respiratory system—chronic obstructive pulmonary disease	0.0216	0.096	CbGeAlD
Adefovir Dipivoxil—AK4—respiratory system—chronic obstructive pulmonary disease	0.0208	0.0925	CbGeAlD
Adefovir Dipivoxil—NME2—respiratory system—chronic obstructive pulmonary disease	0.0203	0.0904	CbGeAlD
Adefovir Dipivoxil—NME1—connective tissue—chronic obstructive pulmonary disease	0.019	0.0845	CbGeAlD
Adefovir Dipivoxil—AK4—bronchus—chronic obstructive pulmonary disease	0.0171	0.0761	CbGeAlD
Adefovir Dipivoxil—NME2—bronchus—chronic obstructive pulmonary disease	0.0167	0.0744	CbGeAlD
Adefovir Dipivoxil—AK4—trachea—chronic obstructive pulmonary disease	0.0154	0.0683	CbGeAlD
Adefovir Dipivoxil—AK2—lung—chronic obstructive pulmonary disease	0.0149	0.0664	CbGeAlD
Adefovir Dipivoxil—Foetor hepaticus—Montelukast—chronic obstructive pulmonary disease	0.0131	0.0186	CcSEcCtD
Adefovir Dipivoxil—NME1—lung—chronic obstructive pulmonary disease	0.0115	0.051	CbGeAlD
Adefovir Dipivoxil—AK4—lung—chronic obstructive pulmonary disease	0.011	0.0491	CbGeAlD
Adefovir Dipivoxil—Liver disorder—Montelukast—chronic obstructive pulmonary disease	0.0109	0.0155	CcSEcCtD
Adefovir Dipivoxil—NME2—lung—chronic obstructive pulmonary disease	0.0108	0.048	CbGeAlD
Adefovir Dipivoxil—Bone pain—Tiotropium—chronic obstructive pulmonary disease	0.00983	0.014	CcSEcCtD
Adefovir Dipivoxil—Tenofovir—CYP1A2—chronic obstructive pulmonary disease	0.00981	1	CrCbGaD
Adefovir Dipivoxil—ABCC5—bronchus—chronic obstructive pulmonary disease	0.00971	0.0432	CbGeAlD
Adefovir Dipivoxil—Glycosuria—Formoterol—chronic obstructive pulmonary disease	0.00938	0.0133	CcSEcCtD
Adefovir Dipivoxil—Glycosuria—Arformoterol—chronic obstructive pulmonary disease	0.00938	0.0133	CcSEcCtD
Adefovir Dipivoxil—Glycosuria—Salbutamol—chronic obstructive pulmonary disease	0.00886	0.0126	CcSEcCtD
Adefovir Dipivoxil—Weight decreased—Roflumilast—chronic obstructive pulmonary disease	0.0085	0.0121	CcSEcCtD
Adefovir Dipivoxil—Hepatobiliary disease—Roflumilast—chronic obstructive pulmonary disease	0.00792	0.0113	CcSEcCtD
Adefovir Dipivoxil—Sinusitis—Roflumilast—chronic obstructive pulmonary disease	0.00786	0.0112	CcSEcCtD
Adefovir Dipivoxil—Cough increased—Salbutamol—chronic obstructive pulmonary disease	0.00784	0.0111	CcSEcCtD
Adefovir Dipivoxil—Hyperkalaemia—Formoterol—chronic obstructive pulmonary disease	0.00747	0.0106	CcSEcCtD
Adefovir Dipivoxil—Hyperkalaemia—Arformoterol—chronic obstructive pulmonary disease	0.00747	0.0106	CcSEcCtD
Adefovir Dipivoxil—Hepatocellular injury—Montelukast—chronic obstructive pulmonary disease	0.00744	0.0106	CcSEcCtD
Adefovir Dipivoxil—SLC22A3—connective tissue—chronic obstructive pulmonary disease	0.00743	0.033	CbGeAlD
Adefovir Dipivoxil—Connective tissue disorder—Roflumilast—chronic obstructive pulmonary disease	0.00739	0.0105	CcSEcCtD
Adefovir Dipivoxil—SLC22A3—smooth muscle tissue—chronic obstructive pulmonary disease	0.00679	0.0302	CbGeAlD
Adefovir Dipivoxil—ABCC4—bronchus—chronic obstructive pulmonary disease	0.00673	0.0299	CbGeAlD
Adefovir Dipivoxil—Malnutrition—Roflumilast—chronic obstructive pulmonary disease	0.00655	0.00931	CcSEcCtD
Adefovir Dipivoxil—NME1—Arf6 downstream pathway—PLAUR—chronic obstructive pulmonary disease	0.00644	0.104	CbGpPWpGaD
Adefovir Dipivoxil—Back pain—Roflumilast—chronic obstructive pulmonary disease	0.00633	0.009	CcSEcCtD
Adefovir Dipivoxil—ABCC5—lung—chronic obstructive pulmonary disease	0.00627	0.0279	CbGeAlD
Adefovir Dipivoxil—Myopathy—Prednisolone—chronic obstructive pulmonary disease	0.00587	0.00834	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Roflumilast—chronic obstructive pulmonary disease	0.00557	0.00792	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Roflumilast—chronic obstructive pulmonary disease	0.00553	0.00787	CcSEcCtD
Adefovir Dipivoxil—Haematuria—Aminophylline—chronic obstructive pulmonary disease	0.00533	0.00757	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Roflumilast—chronic obstructive pulmonary disease	0.00524	0.00745	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Roflumilast—chronic obstructive pulmonary disease	0.00519	0.00738	CcSEcCtD
Adefovir Dipivoxil—Renal failure—Tiotropium—chronic obstructive pulmonary disease	0.00518	0.00736	CcSEcCtD
Adefovir Dipivoxil—Multiple fractures—Prednisone—chronic obstructive pulmonary disease	0.00515	0.00732	CcSEcCtD
Adefovir Dipivoxil—Fracture—Prednisone—chronic obstructive pulmonary disease	0.00515	0.00732	CcSEcCtD
Adefovir Dipivoxil—Sinusitis—Tiotropium—chronic obstructive pulmonary disease	0.00494	0.00703	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Roflumilast—chronic obstructive pulmonary disease	0.00487	0.00692	CcSEcCtD
Adefovir Dipivoxil—Alanine aminotransferase increased—Montelukast—chronic obstructive pulmonary disease	0.00477	0.00677	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Roflumilast—chronic obstructive pulmonary disease	0.0047	0.00668	CcSEcCtD
Adefovir Dipivoxil—Pharyngitis—Tiotropium—chronic obstructive pulmonary disease	0.00469	0.00667	CcSEcCtD
Adefovir Dipivoxil—Urinary tract disorder—Tiotropium—chronic obstructive pulmonary disease	0.00467	0.00664	CcSEcCtD
Adefovir Dipivoxil—Connective tissue disorder—Tiotropium—chronic obstructive pulmonary disease	0.00465	0.00661	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Roflumilast—chronic obstructive pulmonary disease	0.00464	0.0066	CcSEcCtD
Adefovir Dipivoxil—Urethral disorder—Tiotropium—chronic obstructive pulmonary disease	0.00464	0.00659	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.00461	0.00656	CcSEcCtD
Adefovir Dipivoxil—Pancreatitis—Montelukast—chronic obstructive pulmonary disease	0.00458	0.00651	CcSEcCtD
Adefovir Dipivoxil—SLC22A3—lung—chronic obstructive pulmonary disease	0.00448	0.0199	CbGeAlD
Adefovir Dipivoxil—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.00437	0.00621	CcSEcCtD
Adefovir Dipivoxil—ABCC4—lung—chronic obstructive pulmonary disease	0.00434	0.0193	CbGeAlD
Adefovir Dipivoxil—Myopathy—Prednisone—chronic obstructive pulmonary disease	0.00426	0.00606	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.00422	0.006	CcSEcCtD
Adefovir Dipivoxil—Malnutrition—Tiotropium—chronic obstructive pulmonary disease	0.00412	0.00585	CcSEcCtD
Adefovir Dipivoxil—Jaundice—Montelukast—chronic obstructive pulmonary disease	0.00406	0.00577	CcSEcCtD
Adefovir Dipivoxil—Haematuria—Formoterol—chronic obstructive pulmonary disease	0.00405	0.00576	CcSEcCtD
Adefovir Dipivoxil—Haematuria—Arformoterol—chronic obstructive pulmonary disease	0.00405	0.00576	CcSEcCtD
Adefovir Dipivoxil—Sinusitis—Arformoterol—chronic obstructive pulmonary disease	0.00399	0.00567	CcSEcCtD
Adefovir Dipivoxil—Sinusitis—Formoterol—chronic obstructive pulmonary disease	0.00399	0.00567	CcSEcCtD
Adefovir Dipivoxil—Back pain—Tiotropium—chronic obstructive pulmonary disease	0.00398	0.00566	CcSEcCtD
Adefovir Dipivoxil—Hepatobiliary disease—Montelukast—chronic obstructive pulmonary disease	0.00394	0.0056	CcSEcCtD
Adefovir Dipivoxil—Jaundice—Salbutamol—chronic obstructive pulmonary disease	0.00391	0.00556	CcSEcCtD
Adefovir Dipivoxil—Sinusitis—Montelukast—chronic obstructive pulmonary disease	0.00391	0.00555	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.00383	0.00545	CcSEcCtD
Adefovir Dipivoxil—Haematuria—Salbutamol—chronic obstructive pulmonary disease	0.00383	0.00544	CcSEcCtD
Adefovir Dipivoxil—Pharyngitis—Formoterol—chronic obstructive pulmonary disease	0.00379	0.00538	CcSEcCtD
Adefovir Dipivoxil—Pharyngitis—Arformoterol—chronic obstructive pulmonary disease	0.00379	0.00538	CcSEcCtD
Adefovir Dipivoxil—Urinary tract disorder—Arformoterol—chronic obstructive pulmonary disease	0.00377	0.00536	CcSEcCtD
Adefovir Dipivoxil—Urinary tract disorder—Formoterol—chronic obstructive pulmonary disease	0.00377	0.00536	CcSEcCtD
Adefovir Dipivoxil—Sinusitis—Salbutamol—chronic obstructive pulmonary disease	0.00377	0.00535	CcSEcCtD
Adefovir Dipivoxil—Connective tissue disorder—Formoterol—chronic obstructive pulmonary disease	0.00375	0.00533	CcSEcCtD
Adefovir Dipivoxil—Connective tissue disorder—Arformoterol—chronic obstructive pulmonary disease	0.00375	0.00533	CcSEcCtD
Adefovir Dipivoxil—Urethral disorder—Arformoterol—chronic obstructive pulmonary disease	0.00374	0.00532	CcSEcCtD
Adefovir Dipivoxil—Urethral disorder—Formoterol—chronic obstructive pulmonary disease	0.00374	0.00532	CcSEcCtD
Adefovir Dipivoxil—Hepatitis—Montelukast—chronic obstructive pulmonary disease	0.00374	0.00531	CcSEcCtD
Adefovir Dipivoxil—Pharyngitis—Montelukast—chronic obstructive pulmonary disease	0.00371	0.00527	CcSEcCtD
Adefovir Dipivoxil—Glycosuria—Prednisone—chronic obstructive pulmonary disease	0.00369	0.00525	CcSEcCtD
Adefovir Dipivoxil—Urinary tract disorder—Montelukast—chronic obstructive pulmonary disease	0.00369	0.00525	CcSEcCtD
Adefovir Dipivoxil—Connective tissue disorder—Montelukast—chronic obstructive pulmonary disease	0.00367	0.00522	CcSEcCtD
Adefovir Dipivoxil—Urethral disorder—Montelukast—chronic obstructive pulmonary disease	0.00366	0.00521	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.00366	0.0052	CcSEcCtD
Adefovir Dipivoxil—Cough—Tiotropium—chronic obstructive pulmonary disease	0.00359	0.00511	CcSEcCtD
Adefovir Dipivoxil—Pharyngitis—Salbutamol—chronic obstructive pulmonary disease	0.00358	0.00508	CcSEcCtD
Adefovir Dipivoxil—Urinary tract disorder—Salbutamol—chronic obstructive pulmonary disease	0.00356	0.00506	CcSEcCtD
Adefovir Dipivoxil—Connective tissue disorder—Salbutamol—chronic obstructive pulmonary disease	0.00354	0.00503	CcSEcCtD
Adefovir Dipivoxil—Urethral disorder—Salbutamol—chronic obstructive pulmonary disease	0.00353	0.00502	CcSEcCtD
Adefovir Dipivoxil—Chest pain—Tiotropium—chronic obstructive pulmonary disease	0.0035	0.00498	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Tiotropium—chronic obstructive pulmonary disease	0.0035	0.00498	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.00349	0.00497	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.00348	0.00495	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.0034	0.00483	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.0034	0.00483	CcSEcCtD
Adefovir Dipivoxil—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00337	0.00479	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00337	0.00478	CcSEcCtD
Adefovir Dipivoxil—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00335	0.00476	CcSEcCtD
Adefovir Dipivoxil—Malnutrition—Formoterol—chronic obstructive pulmonary disease	0.00332	0.00472	CcSEcCtD
Adefovir Dipivoxil—Malnutrition—Arformoterol—chronic obstructive pulmonary disease	0.00332	0.00472	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.00329	0.00468	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.00326	0.00464	CcSEcCtD
Adefovir Dipivoxil—Back pain—Formoterol—chronic obstructive pulmonary disease	0.00321	0.00457	CcSEcCtD
Adefovir Dipivoxil—Back pain—Arformoterol—chronic obstructive pulmonary disease	0.00321	0.00457	CcSEcCtD
Adefovir Dipivoxil—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00317	0.00451	CcSEcCtD
Adefovir Dipivoxil—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	0.00314	0.00446	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.00314	0.00446	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.0031	0.0044	CcSEcCtD
Adefovir Dipivoxil—Flatulence—Salbutamol—chronic obstructive pulmonary disease	0.00309	0.00439	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.00306	0.00435	CcSEcCtD
Adefovir Dipivoxil—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.00303	0.00431	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.00296	0.0042	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.00291	0.00414	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.0029	0.00412	CcSEcCtD
Adefovir Dipivoxil—Cough—Arformoterol—chronic obstructive pulmonary disease	0.0029	0.00412	CcSEcCtD
Adefovir Dipivoxil—Cough—Formoterol—chronic obstructive pulmonary disease	0.0029	0.00412	CcSEcCtD
Adefovir Dipivoxil—Cough—Montelukast—chronic obstructive pulmonary disease	0.00284	0.00404	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.00283	0.00402	CcSEcCtD
Adefovir Dipivoxil—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.00283	0.00402	CcSEcCtD
Adefovir Dipivoxil—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.00283	0.00402	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.00283	0.00402	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.00282	0.004	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.00282	0.004	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.00281	0.00399	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.00281	0.00399	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.00277	0.00394	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.00275	0.00391	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.00275	0.00391	CcSEcCtD
Adefovir Dipivoxil—Cough—Salbutamol—chronic obstructive pulmonary disease	0.00274	0.00389	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.00267	0.0038	CcSEcCtD
Adefovir Dipivoxil—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.00267	0.0038	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.00266	0.00378	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00266	0.00378	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.00266	0.00378	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.00263	0.00374	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.00263	0.00374	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.0026	0.0037	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.0026	0.0037	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.00258	0.00367	CcSEcCtD
Adefovir Dipivoxil—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.00253	0.0036	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00252	0.00358	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00251	0.00357	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.00249	0.00353	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.00247	0.00351	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00247	0.00351	CcSEcCtD
Adefovir Dipivoxil—NME1—Arf6 trafficking events—ADRB2—chronic obstructive pulmonary disease	0.00246	0.0397	CbGpPWpGaD
Adefovir Dipivoxil—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.00244	0.00347	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00244	0.00347	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.00242	0.00344	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.00239	0.00339	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.00239	0.00339	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00238	0.00338	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00234	0.00333	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00234	0.00333	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.00234	0.00332	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00233	0.00332	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00229	0.00326	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00227	0.00322	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.00225	0.0032	CcSEcCtD
Adefovir Dipivoxil—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00225	0.00319	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00224	0.00319	CcSEcCtD
Adefovir Dipivoxil—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00223	0.00317	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.00223	0.00316	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.00222	0.00315	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.00222	0.00315	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00221	0.00314	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.00217	0.00309	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.00214	0.00305	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.00214	0.00305	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.00214	0.00305	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.00214	0.00305	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00214	0.00304	CcSEcCtD
Adefovir Dipivoxil—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00212	0.00301	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00212	0.00301	CcSEcCtD
Adefovir Dipivoxil—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00212	0.00301	CcSEcCtD
Adefovir Dipivoxil—Headache—Tiotropium—chronic obstructive pulmonary disease	0.0021	0.00299	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.0021	0.00298	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.0021	0.00298	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.00209	0.00298	CcSEcCtD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.00209	0.0337	CbGpPWpGaD
Adefovir Dipivoxil—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.00202	0.00288	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.00202	0.00288	CcSEcCtD
Adefovir Dipivoxil—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.002	0.00284	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.00195	0.00277	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.00195	0.00277	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00192	0.00273	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00192	0.00273	CcSEcCtD
Adefovir Dipivoxil—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.00191	0.00272	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.00191	0.00271	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00188	0.00267	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.00186	0.00264	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.00186	0.00264	CcSEcCtD
Adefovir Dipivoxil—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.00184	0.00262	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.00184	0.00261	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.00182	0.00258	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00181	0.00257	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.00175	0.00249	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00172	0.00245	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00172	0.00245	CcSEcCtD
Adefovir Dipivoxil—Rash—Formoterol—chronic obstructive pulmonary disease	0.00171	0.00243	CcSEcCtD
Adefovir Dipivoxil—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00171	0.00243	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00171	0.00243	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00171	0.00243	CcSEcCtD
Adefovir Dipivoxil—Headache—Formoterol—chronic obstructive pulmonary disease	0.0017	0.00241	CcSEcCtD
Adefovir Dipivoxil—Headache—Arformoterol—chronic obstructive pulmonary disease	0.0017	0.00241	CcSEcCtD
Adefovir Dipivoxil—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.0017	0.00241	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00169	0.0024	CcSEcCtD
Adefovir Dipivoxil—Rash—Montelukast—chronic obstructive pulmonary disease	0.00167	0.00238	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00167	0.00238	CcSEcCtD
Adefovir Dipivoxil—Headache—Montelukast—chronic obstructive pulmonary disease	0.00166	0.00237	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00163	0.00231	CcSEcCtD
Adefovir Dipivoxil—Rash—Salbutamol—chronic obstructive pulmonary disease	0.00161	0.00229	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.00161	0.00229	CcSEcCtD
Adefovir Dipivoxil—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00161	0.00229	CcSEcCtD
Adefovir Dipivoxil—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00161	0.00229	CcSEcCtD
Adefovir Dipivoxil—Headache—Salbutamol—chronic obstructive pulmonary disease	0.0016	0.00228	CcSEcCtD
Adefovir Dipivoxil—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00158	0.00224	CcSEcCtD
Adefovir Dipivoxil—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00152	0.00216	CcSEcCtD
Adefovir Dipivoxil—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.00148	0.0021	CcSEcCtD
Adefovir Dipivoxil—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.00131	0.00186	CcSEcCtD
Adefovir Dipivoxil—SLC22A3—Synaptic Vesicle Pathway—SLC6A4—chronic obstructive pulmonary disease	0.00127	0.0205	CbGpPWpGaD
Adefovir Dipivoxil—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.00121	0.00172	CcSEcCtD
Adefovir Dipivoxil—ABCC5—NRF2 pathway—SOD3—chronic obstructive pulmonary disease	0.00113	0.0182	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—APIP—chronic obstructive pulmonary disease	0.00112	0.018	CbGpPWpGaD
Adefovir Dipivoxil—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.00111	0.00158	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.00111	0.00157	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.00105	0.00149	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.00104	0.00147	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.00102	0.00145	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000972	0.00138	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000939	0.00134	CcSEcCtD
Adefovir Dipivoxil—NME2—Validated targets of C-MYC transcriptional activation—MMP9—chronic obstructive pulmonary disease	0.000935	0.0151	CbGpPWpGaD
Adefovir Dipivoxil—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000928	0.00132	CcSEcCtD
Adefovir Dipivoxil—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000926	0.00132	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000925	0.00131	CcSEcCtD
Adefovir Dipivoxil—Headache—Prednisolone—chronic obstructive pulmonary disease	0.00092	0.00131	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Platelet degranulation—SERPINA1—chronic obstructive pulmonary disease	0.000901	0.0146	CbGpPWpGaD
Adefovir Dipivoxil—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000873	0.00124	CcSEcCtD
Adefovir Dipivoxil—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000872	0.00124	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Response to elevated platelet cytosolic Ca2+—SERPINA1—chronic obstructive pulmonary disease	0.000858	0.0139	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Posttranslational regulation of adherens junction stability and dissassembly—EGFR—chronic obstructive pulmonary disease	0.000853	0.0138	CbGpPWpGaD
Adefovir Dipivoxil—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000844	0.0012	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000844	0.0012	CcSEcCtD
Adefovir Dipivoxil—ABCC5—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000829	0.0134	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—NRF2 pathway—SERPINA1—chronic obstructive pulmonary disease	0.000803	0.013	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—NRF2 pathway—SOD3—chronic obstructive pulmonary disease	0.000781	0.0126	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet degranulation—TGFB2—chronic obstructive pulmonary disease	0.000781	0.0126	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—APIP—chronic obstructive pulmonary disease	0.000773	0.0125	CbGpPWpGaD
Adefovir Dipivoxil—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000766	0.00109	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000755	0.00107	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Response to elevated platelet cytosolic Ca2+—TGFB2—chronic obstructive pulmonary disease	0.000744	0.012	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000739	0.0119	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000739	0.0119	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—NRF2 pathway—GCLC—chronic obstructive pulmonary disease	0.000734	0.0119	CbGpPWpGaD
Adefovir Dipivoxil—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.00073	0.00104	CcSEcCtD
Adefovir Dipivoxil—AK2—Metabolism—GC—chronic obstructive pulmonary disease	0.000719	0.0116	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Validated targets of C-MYC transcriptional activation—MMP9—chronic obstructive pulmonary disease	0.000708	0.0114	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—NRF2 pathway—TGFB2—chronic obstructive pulmonary disease	0.000696	0.0112	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—RAPGEF3—chronic obstructive pulmonary disease	0.000695	0.0112	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—NRF2 pathway—SLC6A4—chronic obstructive pulmonary disease	0.000683	0.011	CbGpPWpGaD
Adefovir Dipivoxil—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000678	0.000964	CcSEcCtD
Adefovir Dipivoxil—Rash—Prednisone—chronic obstructive pulmonary disease	0.000673	0.000956	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000672	0.000956	CcSEcCtD
Adefovir Dipivoxil—Headache—Prednisone—chronic obstructive pulmonary disease	0.000668	0.00095	CcSEcCtD
Adefovir Dipivoxil—AK2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000668	0.0108	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000665	0.0107	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Validated targets of C-MYC transcriptional activation—TP53—chronic obstructive pulmonary disease	0.000634	0.0102	CbGpPWpGaD
Adefovir Dipivoxil—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000634	0.000901	CcSEcCtD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000599	0.00969	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000593	0.00958	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—APIP—chronic obstructive pulmonary disease	0.000586	0.00947	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000575	0.00929	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—NRF2 pathway—SERPINA1—chronic obstructive pulmonary disease	0.000557	0.00899	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000534	0.00863	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Fluoropyrimidine Activity—TP53—chronic obstructive pulmonary disease	0.000522	0.00843	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—NRF2 pathway—GSTP1—chronic obstructive pulmonary disease	0.000515	0.00832	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000512	0.00828	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000512	0.00828	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—NRF2 pathway—GCLC—chronic obstructive pulmonary disease	0.000509	0.00823	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—NRF2 pathway—HMOX1—chronic obstructive pulmonary disease	0.000508	0.00821	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.0005	0.00808	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—GC—chronic obstructive pulmonary disease	0.000498	0.00805	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—NRF2 pathway—TGFB2—chronic obstructive pulmonary disease	0.000483	0.0078	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Validated targets of C-MYC transcriptional activation—TP53—chronic obstructive pulmonary disease	0.000481	0.00777	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—NRF2 pathway—GSTM1—chronic obstructive pulmonary disease	0.000473	0.00765	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—NRF2 pathway—SLC6A4—chronic obstructive pulmonary disease	0.000473	0.00765	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000463	0.00749	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000446	0.00721	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—SERPINE2—chronic obstructive pulmonary disease	0.00041	0.00663	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—SERPINA1—chronic obstructive pulmonary disease	0.000399	0.00645	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000393	0.00635	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000388	0.00627	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000388	0.00627	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—GC—chronic obstructive pulmonary disease	0.000378	0.0061	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Fluoropyrimidine Activity—TP53—chronic obstructive pulmonary disease	0.000362	0.00584	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—RAPGEF3—chronic obstructive pulmonary disease	0.000358	0.00579	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—NRF2 pathway—GSTP1—chronic obstructive pulmonary disease	0.000357	0.00577	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000354	0.00573	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—NRF2 pathway—HMOX1—chronic obstructive pulmonary disease	0.000352	0.00569	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000351	0.00567	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—TGFB2—chronic obstructive pulmonary disease	0.000346	0.0056	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet degranulation—SERPINE1—chronic obstructive pulmonary disease	0.000343	0.00554	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet degranulation—ALB—chronic obstructive pulmonary disease	0.000342	0.00553	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—NRF2 pathway—GSTM1—chronic obstructive pulmonary disease	0.000328	0.0053	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000326	0.00528	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Response to elevated platelet cytosolic Ca2+—SERPINE1—chronic obstructive pulmonary disease	0.000326	0.00528	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Response to elevated platelet cytosolic Ca2+—ALB—chronic obstructive pulmonary disease	0.000326	0.00527	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—APIP—chronic obstructive pulmonary disease	0.000317	0.00512	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	0.000314	0.00507	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	0.000288	0.00466	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	0.000282	0.00456	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000272	0.0044	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000272	0.0044	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000269	0.00435	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	0.000269	0.00435	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000269	0.00434	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—APIP—chronic obstructive pulmonary disease	0.000254	0.0041	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.00025	0.00404	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000246	0.00397	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000237	0.00383	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	0.000237	0.00383	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet degranulation—VEGFA—chronic obstructive pulmonary disease	0.000236	0.00381	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000226	0.00366	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—chronic obstructive pulmonary disease	0.000225	0.00363	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet degranulation—TGFB1—chronic obstructive pulmonary disease	0.000216	0.0035	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.00021	0.00339	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000206	0.00333	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Response to elevated platelet cytosolic Ca2+—TGFB1—chronic obstructive pulmonary disease	0.000206	0.00333	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	0.000206	0.00333	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000204	0.0033	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—GC—chronic obstructive pulmonary disease	0.000204	0.0033	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	0.000193	0.00312	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.00019	0.00306	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000189	0.00305	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000186	0.00301	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000186	0.00301	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—TGFB2—chronic obstructive pulmonary disease	0.000179	0.00288	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000173	0.0028	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000171	0.00277	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000168	0.00272	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000164	0.00266	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—GC—chronic obstructive pulmonary disease	0.000164	0.00264	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000163	0.00263	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—ALB—chronic obstructive pulmonary disease	0.000161	0.00261	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—HDAC2—chronic obstructive pulmonary disease	0.00016	0.00259	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—NOS3—chronic obstructive pulmonary disease	0.000154	0.00249	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	0.000154	0.00249	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000152	0.00246	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	0.000152	0.00246	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—ALB—chronic obstructive pulmonary disease	0.000152	0.00245	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—PLAUR—chronic obstructive pulmonary disease	0.000144	0.00233	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000143	0.00231	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000141	0.00228	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	0.000139	0.00225	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	0.000134	0.00216	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000131	0.00212	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.00013	0.00211	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000125	0.00201	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000118	0.0019	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	0.000116	0.00187	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000113	0.00182	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—HDAC2—chronic obstructive pulmonary disease	0.000112	0.00181	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—ALB—chronic obstructive pulmonary disease	0.000112	0.00181	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000111	0.0018	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—GCLC—chronic obstructive pulmonary disease	0.00011	0.00178	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—NOS3—chronic obstructive pulmonary disease	0.000107	0.00173	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	0.000105	0.00169	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—KL—chronic obstructive pulmonary disease	0.000104	0.00168	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—MMP1—chronic obstructive pulmonary disease	0.000103	0.00167	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—PLAU—chronic obstructive pulmonary disease	0.000101	0.00164	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000101	0.00162	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	9.81e-05	0.00159	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	9.77e-05	0.00158	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	9.6e-05	0.00155	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—NOS2—chronic obstructive pulmonary disease	9.3e-05	0.0015	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.26e-05	0.0015	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.94e-05	0.00144	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—GCLC—chronic obstructive pulmonary disease	8.83e-05	0.00143	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—ALB—chronic obstructive pulmonary disease	8.47e-05	0.00137	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—NOS3—chronic obstructive pulmonary disease	8.1e-05	0.00131	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—CTGF—chronic obstructive pulmonary disease	8.06e-05	0.0013	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	7.83e-05	0.00127	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	7.83e-05	0.00127	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—ALB—chronic obstructive pulmonary disease	7.82e-05	0.00126	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—ERBB3—chronic obstructive pulmonary disease	7.79e-05	0.00126	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.72e-05	0.00125	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.62e-05	0.00123	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—NOS3—chronic obstructive pulmonary disease	7.48e-05	0.00121	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.43e-05	0.0012	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.1e-05	0.00115	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	7.06e-05	0.00114	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	6.77e-05	0.00109	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.73e-05	0.00109	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—NOS2—chronic obstructive pulmonary disease	6.5e-05	0.00105	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.2e-05	0.001	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.11e-05	0.000987	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	5.89e-05	0.000952	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.69e-05	0.00092	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—SERPINE1—chronic obstructive pulmonary disease	5.47e-05	0.000884	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.4e-05	0.000872	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—VEGFA—chronic obstructive pulmonary disease	5.39e-05	0.000871	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—NOS3—chronic obstructive pulmonary disease	5.22e-05	0.000844	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—TGFB1—chronic obstructive pulmonary disease	4.95e-05	0.000799	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—ALB—chronic obstructive pulmonary disease	4.57e-05	0.000739	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—NOS3—chronic obstructive pulmonary disease	4.38e-05	0.000707	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—TP53—chronic obstructive pulmonary disease	4.07e-05	0.000658	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—ALB—chronic obstructive pulmonary disease	3.67e-05	0.000593	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—NOS3—chronic obstructive pulmonary disease	3.51e-05	0.000567	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—TGFB1—chronic obstructive pulmonary disease	3.45e-05	0.000558	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—EGFR—chronic obstructive pulmonary disease	3.39e-05	0.000547	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—IL6—chronic obstructive pulmonary disease	2.6e-05	0.000421	CbGpPWpGaD
